Barclays PLC Lexicon Pharmaceuticals, Inc. Call Options Transaction History

Barclays PLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 10, 2020	SELL	$3.16 - $5.15 $2,212 - $3,605	-700 Reduced 41.18%	1,000 $4,000
Q3 2019 Nov 14, 2019	BUY	$1.2 - $6.66 $1,200 - $6,660	1,000 Added 142.86%	1,700 $5,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.11 $18,725 - $24,885	-3,500 Reduced 83.33%	700 $4,000
Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $17,004 - $30,966	3,900 Added 1300.0%	4,200 $23,000
Q3 2018 Nov 14, 2018	SELL	$10.32 - $13.06 $10,320 - $13,060	-1,000 Reduced 76.92%	300 $3,000
Q1 2018 May 15, 2018	BUY	$7.86 - $11.39 $4,716 - $6,834	600 Added 85.71%	1,300 $11,000
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $8,519 - $11,410	700	700 $9,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.